TD Asset Management Inc Increases Stock Holdings in Celcuity, Inc. $CELC

TD Asset Management Inc boosted its position in shares of Celcuity, Inc. (NASDAQ:CELC) by 34.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 97,526 shares of the company’s stock after acquiring an additional 24,730 shares during the period. TD Asset Management Inc’s holdings in Celcuity were worth $9,727,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of CELC. Creative Planning bought a new position in Celcuity in the 2nd quarter valued at $177,000. Rhumbline Advisers increased its holdings in shares of Celcuity by 1.2% in the second quarter. Rhumbline Advisers now owns 42,697 shares of the company’s stock worth $570,000 after purchasing an additional 503 shares during the period. XTX Topco Ltd bought a new position in shares of Celcuity in the second quarter worth $169,000. Quantinno Capital Management LP raised its position in shares of Celcuity by 20.7% in the second quarter. Quantinno Capital Management LP now owns 243,042 shares of the company’s stock worth $3,245,000 after buying an additional 41,756 shares in the last quarter. Finally, Paloma Partners Management Co raised its position in shares of Celcuity by 285.8% in the second quarter. Paloma Partners Management Co now owns 82,137 shares of the company’s stock worth $1,097,000 after buying an additional 60,849 shares in the last quarter. Institutional investors own 63.33% of the company’s stock.

Insider Activity at Celcuity

In other news, Director David Dalvey sold 25,000 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were sold at an average price of $140.68, for a total value of $3,517,000.00. Following the completion of the sale, the director directly owned 65,000 shares in the company, valued at approximately $9,144,200. The trade was a 27.78% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Richard E. Buller sold 9,000 shares of the company’s stock in a transaction on Monday, May 4th. The shares were sold at an average price of $140.46, for a total transaction of $1,264,140.00. Following the completion of the sale, the director directly owned 6,760 shares of the company’s stock, valued at $949,509.60. This trade represents a 57.11% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 37,000 shares of company stock worth $5,111,950 over the last three months. Insiders own 13.33% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on CELC shares. Citizens Jmp boosted their target price on Celcuity from $150.00 to $160.00 and gave the stock a “market outperform” rating in a research report on Monday, May 4th. Macquarie Infrastructure set a $160.00 price target on Celcuity in a research report on Thursday, May 28th. Wolfe Research reissued an “outperform” rating and set a $110.00 price objective on shares of Celcuity in a report on Thursday, March 12th. Wells Fargo & Company lowered their target price on shares of Celcuity from $183.00 to $166.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 3rd. Finally, Citigroup reiterated a “market outperform” rating on shares of Celcuity in a research report on Thursday, May 28th. Eleven investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $152.09.

Celcuity Price Performance

Shares of Celcuity stock opened at $92.59 on Wednesday. The firm has a market capitalization of $4.52 billion, a PE ratio of -23.74 and a beta of 0.10. The company has a current ratio of 12.31, a quick ratio of 12.31 and a debt-to-equity ratio of 6.04. Celcuity, Inc. has a 12 month low of $11.27 and a 12 month high of $151.02. The business’s 50-day moving average price is $121.19 and its 200-day moving average price is $111.48.

Celcuity (NASDAQ:CELC) last released its earnings results on Thursday, May 14th. The company reported ($0.97) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.07) by $0.10. Sell-side analysts forecast that Celcuity, Inc. will post -3.69 EPS for the current fiscal year.

Celcuity Company Profile

Celcuity, Inc is a clinical-stage biotechnology company specializing in precision oncology diagnostics. The company develops and commercializes predictive biomarker assays designed to identify which patients are most likely to benefit from targeted cancer therapies. By integrating functional profiling of tumor cells with molecular analyses, Celcuity seeks to optimize treatment selection and improve outcomes for patients with solid tumors.

Celcuity’s proprietary platform evaluates tumor cell sensitivity to various therapeutic agents using ex vivo assays that measure DNA damage response and other critical pathways.